Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VanDeMark Chemical is a private specialty chemical manufacturer focused on phosgene, phosgene derivatives, and custom complex chemistries used across life sciences and industrial markets. The company supplies fine chemical intermediates and offers custom manufacturing, process development, scale-up, quality support, and regulatory-oriented manufacturing services for pharmaceutical and other highly regulated applications. VanDeMark emphasizes phosgenation and related chemistries, including chlorination, hydrazine, acylation, esterification, and distillation, and operates manufacturing in the United States and Hungary. While it is not a drug developer, it is relevant to the life sciences ecosystem as a producer of specialty intermediates and manufacturing services for pharmaceutical customers. The company has been owned by Comvest Partners since 2019, with SK Capital joining as an investor and co-owner in 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VanDeMark Chemical.